These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2142057)

  • 21. Apolipoprotein e4 allele is predictor of coronary artery disease death in elderly patients with type 2 diabetes mellitus.
    Guang-da X; You-ying L; Zhi-song C; Yu-sheng H; Xiang-jiu Y
    Atherosclerosis; 2004 Jul; 175(1):77-81. PubMed ID: 15186949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia.
    Moriwaki Y; Yamamoto T; Takahashi S; Tsutsumi Z; Higashino K
    Ann Rheum Dis; 1995 May; 54(5):351-4. PubMed ID: 7794039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E genotypes of normal and hyperlipidemic subjects.
    Kim YS; Paeng JR; Woo JT; Kim SW; Yang IM; Kim JW; Kim KW; Choi YK
    J Korean Med Sci; 1993 Aug; 8(4):262-6. PubMed ID: 8198763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan.
    Kobayashi J; Saito Y; Taira K; Hikita M; Takahashi K; Bujo H; Morisaki N; Saito Y
    Atherosclerosis; 2001 Feb; 154(3):539-46. PubMed ID: 11257254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
    Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
    Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype.
    Luc G; Ducimetiere P; Bard JM; Arveiler D; Evans A; Cambien F; Fruchart JC; Fievet C
    Atherosclerosis; 1997 Jun; 131(2):257-62. PubMed ID: 9199280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E2/E3/E4 genotyping with agarose gels.
    Dallinga-Thie GM; van Linde-Sibenius Trip M; Kock LA; De Bruin TW
    Clin Chem; 1995 Jan; 41(1):73-5. PubMed ID: 7813084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis.
    Feussner G; Wey S; Bommer J; Deppermann D; Grützmacher P; Ziegler R
    Hum Genet; 1992 Jan; 88(3):307-12. PubMed ID: 1733833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.
    Couderc R; Mahieux F; Bailleul S; Fenelon G; Mary R; Fermanian J
    Stroke; 1993 May; 24(5):661-4. PubMed ID: 8488520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E polymorphism in diabetic and non-diabetic patients: does it really contribute to atherosclerosis?
    Camsari A; Tamer L; Aras Ateş N; Pekdemir H; Ciçek D; Ercan B; Camdeviren H; Atik U
    Acta Cardiol; 2005 Aug; 60(4):409-14. PubMed ID: 16128374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France).
    Bailleul S; Couderc R; Landais V; Lefèvre G; Raichvarg D; Etienne J
    Hum Hered; 1993; 43(3):159-65. PubMed ID: 8330879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E polymorphism and coronary artery disease.
    Menzel HJ; Kladetzky RG; Assmann G
    Arteriosclerosis; 1983; 3(4):310-5. PubMed ID: 6882285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism.
    Reznik Y; Pousse P; Herrou M; Morello R; Mahoudeau J; Drosdowsky MA; Fradin S
    Metabolism; 1996 Jan; 45(1):63-71. PubMed ID: 8544779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different mobility in SDS--polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes apo E-N and Apo E-D.
    Utermann G; Weber W; Beisiegel U
    FEBS Lett; 1979 May; 101(1):21-6. PubMed ID: 221251
    [No Abstract]   [Full Text] [Related]  

  • 37. Apolipoprotein C subtype distribution in type 2 diabetes mellitus.
    Gomez JA; del Pozo C; Sorribas A; Serrat J; Gonzalez-Sastre F; de Leiva A
    Diabet Med; 1989 Mar; 6(2):127-30. PubMed ID: 2522853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins.
    Ghiselli G; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1984 Jul; 794(2):333-9. PubMed ID: 6428460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E isoforms in diabetes.
    Black S; Brunt RV; Reckless JP
    Monogr Atheroscler; 1985; 13():111-4. PubMed ID: 4088273
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased prevalence of apolipoprotein E2 in patients with retinitis pigmentosa.
    Jahn CE; Oette K; Esser A; von Bergmann K; Leiss O
    Ophthalmic Res; 1987; 19(5):285-8. PubMed ID: 3438047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.